A dipeptide fragment of β-endorphin
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Glycyl-L-Glutamine (hydrate)

Item No. 35058

Technical Information
CAS Number
172669-64-6
Synonyms
  • Glycylglutamine
  • Gly-Gln
Molecular Formula
C7H13N3O4 • H2O
Formula Weight
Purity
≥98%
A solid
Water: soluble
SMILES
NC(CC[C@H](NC(CN)=O)C(O)=O)=O.O
InChi Code
InChI=1S/C7H13N3O4.H2O/c8-3-6(12)10-4(7(13)14)1-2-5(9)11;/h4H,1-3,8H2,(H2,9,11)(H,10,12)(H,13,14);1H2/t4-;/m0./s1
InChi Key
KLFWVRQACSYLOH-WCCKRBBISA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Glycyl-L-glutamine is a C-terminal dipeptide fragment of β-endorphin (Item Nos. 24955 | 24153).1 It decreases reperfusion damage and increases the time to ischemic contracture in isolated rat hearts in a model of cardiac ischemia-reperfusion injury using eight- and 36-week old rats when used at a concentration of 5 mM.2 Glycyl-L-glutamine (1-100 nmol) inhibits morphine-induced respiratory depression with no effect on morphine-induced analgesia in rats.3 It also inhibits acquisition of place preference, delays the development of tolerance, and reduces withdrawal intensity in morphine-conditioned rats.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Parish, D.C., Smyth, D.G., Normanton, J.R., et alGlycyl glutamine, an inhibitory neuropeptide derived from β-endorphin. Nature 306(5940), 267-270 (1983).

    2. Almashhadany, A., Alghamdi, O.A., Van der Touw, T., et alʟ-Glycyl-ʟ-glutamine provides the isolated and perfused young and middle-aged rat heart protection against ischaemia-reperfusion injury. Amino Acids 47(8), 1559-1565 (2015).

    3. Owen, M.D., Unal, C.B., Callahan, M.F., et alGlycyl-glutamine inhibits the respiratory depression, but not the antinociception, produced by morphine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279(5), R1944-R1948 (2000).

    4. Cavun, S., Göktalay, G., and Millington, W.R. Glycyl-glutamine, an endogenous β-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal. J. Pharmacol. Exp. Ther. 315(2), 949-958 (2005).